Clinical protocol - Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease

Heslop, H Rooney, C Brenner, M Krance, R Carrum, G Gahn, B Bollard, C Khan, S Gee, A Popat, U Gresik, M Przepiorka, D Kuehnle, I Grilley, B

H. Heslop et al., Clinical protocol - Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease, HUM GENE TH, 11(10), 2000, pp. 1465-1475

27

Molecular Biology & Genetics

HUMAN GENE THERAPY

10430342 → ACNP

11

10

2000

1465 - 1475

ISI

1043-0342(200007)11:10<1465:CP-AON>2.0.ZU;2-O